Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 7/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4518574 | 1.00 | EPHX2 (0.36) | EPHX2THRBATML3MBTL1HSD11B1 | |
| SCHEMBL29134343 | 0.85 | THRB (0.42) | EPHX2THRBATML3MBTL1EPHX1 | |
| SCHEMBL29134344 | 0.85 | THRB (0.42) | EPHX2THRBATML3MBTL1EPHX1 | |
| SCHEMBL4122335 | 0.81 | THRB (0.47) | EPHX2THRBATML3MBTL1EPHX1 | |
| SCHEMBL671290 | 0.81 | THRB (0.51) | EPHX2THRBATML3MBTL1EPHX1 | |
| SCHEMBL4112587 | 0.81 | THRB (0.51) | EPHX2THRBATML3MBTL1EPHX1 | |
| SCHEMBL5202228 | 0.80 | THRB (0.54) | EPHX2THRBATML3MBTL1EPHX1 | |
| SCHEMBL4114698 | 0.80 | THRB (0.54) | EPHX2THRBATML3MBTL1EPHX1 | |
| SCHEMBL4511809 | 0.79 | OPRK1 (0.41) | EPHX2THRBATML3MBTL1HSD11B1 | |
| SCHEMBL4117506 | 0.77 | MCHR1 (0.42) | THRBATML3MBTL1KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090239929-A1 | N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors | PFIZER INC. | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239929-A1 | N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors | TPH1, TPH2, HTR1A | EPHX2 828/4885THRB 449/4885ATM 4612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.